middle.news
PYC Therapeutics Confirms Safety Milestone for PKD Drug Candidate PYC-003
9:40am on Friday 19th of December, 2025 AEDT
•
Biotechnology
Read Story
PYC Therapeutics Confirms Safety Milestone for PKD Drug Candidate PYC-003
9:40am on Friday 19th of December, 2025 AEDT
Key Points
PYC-003 safe and well tolerated up to 4 mg/kg in healthy volunteers
No serious adverse events reported in Phase 1a/1b Part A
Dosing commenced in PKD patients for Part B of the study
Repeat dosing in patients planned for first half of 2026
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
PYC
OPEN ARTICLE